Table 1 Clinical characteristics, inflammatory markers, brachial-ankle pulse wave velocity, lipid peroxides, and adhesion molecules at baseline and at the 3-year follow-up
Baseline | 3-year follow-up | P | |
|---|---|---|---|
Age (year) | 45.3 ± 0.88 | 48.1 ± 0.89 | <0.001 |
Body mass index (kg/m2) | 24.6 ± 0.32 | 24.6 ± 0.29 | 0.953 |
Waist-to-hip ratio | 0.90 ± 0.01 | 0.91 ± 0.01 | 0.267 |
Systolic BP (mmHg) | 120.1 ± 1.50 | 120.8 ± 1.99 | 0.940 |
Diastolic BP (mmHg) | 74.9 ± 1.35 | 75.2 ± 1.60 | 0.954 |
Triglyceride (mg/dL)a | 137.8 ± 10.7 | 138.8 ± 10.7 | 0.953 |
Total cholesterol (mg/dL)a | 192.4 ± 4.61 | 190.3 ± 4.31 | 0.987 |
HDL cholesterol (mg/dL)a | 51.5 ± 1.87 | 45.3 ± 1.50 | <0.001 |
LDL cholesterol (mg/dL)a | 114.9 ± 4.73 | 118.8 ± 3.95 | 0.119 |
Glucose (mg/dL)a | 93.9 ± 1.55 | 96.0 ± 1.72 | 0.117 |
Insulin (μU/mL)a | 8.34 ± 0.43 | 8.04 ± 0.48 | 0.581 |
HOMA-IRa | 1.94 ± 0.11 | 1.90 ± 0.12 | 0.946 |
hs-CRP (mg/L)a | 1.23 ± 0.25 | 0.84 ± 0.08 | 0.941 |
Serum IL-6 (pg/mL)a | 4.83 ± 0.50 | 4.17 ± 0.46 | 0.130 |
White blood cells (×109/L)a | 6.16 ± 0.31 | 5.77 ± 0.17 | 0.639 |
Adiponectin (μg/mL)a | 5.27 ± 0.31 | 5.39 ± 0.27 | 0.224 |
ba-PWV (cm/s)a | 1,340.3 ± 27.5 | 1,357.2 ± 29.5 | 0.264 |
8-epi-PGF2α (pg/mg creatinine)a | 1,353.8 ± 73.7 | 1,384.6 ± 67.5 | 0.838 |
Malondialdehyde (nmol/mL)a | 9.92 ± 0.31 | 12.4 ± 0.47 | <0.001 |
Oxidized LDL (U/L)a | 34.0 ± 1.46 | 43.0 ± 1.89 | <0.001 |
sICAM-1 (pg/mL) | 193.3 ± 7.65 | 193.5 ± 9.38 | 0.658 |
sVCAM-1 (pg/mL) | 676.5 ± 46.9 | 749.7 ± 65.4 | 0.043 |
P-selectin (pg/mL) | 33.9 ± 1.65 | 37.1 ± 2.20 | 0.153 |